Androgen receptor-modulatory microRNAs provide insight into therapy resistance and therapeutic targets in advanced prostate cancer
Claire Fletcher(Hammersmith Hospital), Charlotte L. Bevan(The London College)
Cited by 70
Related Papers
Single-molecule amplification-free multiplexed detection of circulating microRNA cancer biomarkers from serum
|Nature Communications|2021|236
Manipulating prohibitin levels provides evidence for an in vivo role in androgen regulation of prostate tumours
|Endocrine Related Cancer|2009|56
The CDK7 inhibitor CT7001 (Samuraciclib) targets proliferation pathways to inhibit advanced prostate cancer
|British Journal of Cancer|2023|24